Spectral Diagnostics Inc. (OTCMKTS:EDTXF) Shares Shorted: Short Interest Up 147.6% in October

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 12,731 shares, a growth of 147.6% from the September 30th total of 5,142 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 8,964 shares, the short-interest ratio is currently 1.4 days.

Spectral Diagnostics Trading Up 11.1%

Shares of Spectral Diagnostics stock traded up $0.07 during trading hours on Friday, reaching $0.73. 3,635 shares of the company’s stock were exchanged, compared to its average volume of 8,872. Spectral Diagnostics has a 52-week low of $0.64 and a 52-week high of $1.10. The firm has a market capitalization of $216.50 million, a price-to-earnings ratio of -7.35 and a beta of 0.14. The company has a fifty day moving average of $0.84 and a 200-day moving average of $0.95.

About Spectral Diagnostics

Spectral Diagnostics Inc is a Canadian medical technology company focused on improving the diagnosis and treatment of sepsis and septic shock. The company develops products designed to identify endotoxin activity, an important factor in certain severe infections and inflammatory conditions.

Its principal diagnostic product is the Endotoxin Activity Assay, a blood test intended to measure a patient’s level of endotoxin activity and help identify individuals who may be at increased risk of developing severe sepsis.